Skip to main content
# Title Research Member Research Year
61 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
62 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
63 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Dr. Hanaan Ahmed Mohammed Ahmed 2021
64 Validation of imaging reporting and data system of coronavirus disease 2019 lexicons CO-RADS and COVID-RADS with radiologists’ preference: a multicentric study Dr. Adel Gomaa Mohamed Gabr 2021
65 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
66 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Osama mostafa Abdelbadee Abou elhassan 2021
67 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Dr. Adel Gomaa Mohamed Gabr 2021
68 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
Dr. Mayada Fawzy Sedik Farghaly 2021
69 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
70 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Dr. Maged Abdelfatah Amine Hassan 2021